β-Carboline alkaloids from the roots of Peganum harmala L.

Shengge LI , Qin ZHANG , Yuetong WANG , Bin LIN , Dahong LI , Huiming HUA , Xu HU

Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (2) : 171 -177.

PDF (1031KB)
Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (2) :171 -177. DOI: 10.1016/S1875-5364(24)60583-2
Original article
research-article
β-Carboline alkaloids from the roots of Peganum harmala L.
Author information +
History +
PDF (1031KB)

Abstract

This study reports the isolation of four new β-carboline alkaloids (14) and six previously identified alkaloids (510) from the roots of Peganum harmala L. Among these compounds, 1 and 2 were characterized as rare β-carboline-quinazoline dimers exhibiting axial chirality. Compound 3 possessed a unique 6/5/6/7 tetracyclic ring system with an azepine ring, and compound 4 was a novel annomontine β-carboline. The structures of these compounds were elucidated by spectroscopic data and quantum mechanical calculations. The biosynthetic pathways of 13 were proposed. Additionally, the cytotoxicity of some isolates against four cancer cell lines (HL-60, A549, MDA-MB-231, and DU145) was evaluated. Notably, compound 4 exhibited significant cytotoxicity against HL-60, A549, and DU145 cells with IC50 values of 12.39, 12.80, and 30.65 μmol·L−1, respectively. Furthermore, compound 2 demonstrated selective cytotoxicity against HL-60 cells with an IC50 value of 17.32 μmol·L−1.

Keywords

β-Carboline alkaloids / Peganum harmala / Structure elucidation / Cytotoxic activity

Cite this article

Download citation ▾
Shengge LI, Qin ZHANG, Yuetong WANG, Bin LIN, Dahong LI, Huiming HUA, Xu HU. β-Carboline alkaloids from the roots of Peganum harmala L.. Chinese Journal of Natural Medicines, 2024, 22(2): 171-177 DOI:10.1016/S1875-5364(24)60583-2

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Cao P, Zheng Y, Zhao Y, et al. Beetleane A and epicoane A: two carbon skeletons produced by Epicoccum nigrum[J]. Org Lett, 2021, 23(9): 3274-3277.

[2]

Trigo J, Subbiah V, Besse B, et al. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial[J]. Lancet Oncol, 2020, 21(5): 645-654.

[3]

Lopes-Ortiz MA, Panice MR, Borges ME, et al. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives[J]. Eur J Med Chem, 2020, 187: 111935.

[4]

Jia M, Qin D, Zhao C, et al. Redox homeostasis maintained by GPX4 facilitates STING activation[J]. Nat Immunol, 2020, 21(7): 727-735.

[5]

Wu Z, Chen N, Tang Q, et al. β-Carboline alkaloids from the seeds of Peganum harmala and their anti-HSV-2 virus activities[J]. Org Lett, 2020, 22(18): 7310-7314.

[6]

Li S, Wang Y, Zhang Q, et al. Pegaharmols A-B, axially chiral β-carboline-quinazoline dimers from the roots of Peganum harmala[J]. Org Lett, 2020, 22(19): 7522-7525.

[7]

Ling Y, Gao W, Ling C, et al. β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma[J]. Eur J Med Chem, 2019, 168: 515-526.

[8]

Li S, Cheng X, Wang C. A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum[J]. J Ethnopharmacol, 2017, 203: 127-162.

[9]

Wang KB, Li DH, Bao Y, et al. Structurally diverse alkaloids from the seeds of Peganum harmala[J]. J Nat Prod, 2017, 80(2): 551-559.

[10]

Yang YD, Chen XM, Liu W, et al. Peganumine B-I and two enantiomers: new alkaloids from the seeds of Peganum harmala Linn. and their potential cytotoxicity and cholinesterase inhibitory activities[J]. RSC Adv, 2016, 6(19): 15976-15987.

[11]

Wang KB, Li DH, Hu P, et al. A series of β-carboline alkaloids from the seeds of Peganum harmala show G-quadruplex interactions[J]. Org Lett, 2016, 18(14): 3398-3401.

[12]

Wang KB, Di YT, Bao Y, et al. Peganumine A, a β-carboline dimer with a new octacyclic scaffold from Peganum harmala[J]. Org Lett, 2014, 16(15): 4028-4031.

[13]

Wang KB, Yuan CM, Xue CM, et al. Pegaharmalines A and B, two novel β-carboline alkaloids with unprecedented carbon skeletons from Peganum harmala[J]. RSC Adv, 2014, 4(96): 53725-53729.

[14]

Wang X, Geng Y, Wang D, et al. Separation and purification of harmine and harmaline from Peganum harmala using pH-zone-refining counter-current chromatography[J]. J Sep Sci, 2008, 31(20): 3543-3547.

[15]

Ōki M. Recent Advances in Atropisomerism. In: Allinger NL, Eliel EL, Wilen SH. Topics in Stereochemistry[M]. John Wiley & Sons, 1983: 1-81.

[16]

Kanchanapoom T, Kasai R, Chumsri P, et al. Canthin-6-one and β-carboline alkaloids from Eurycoma harmandiana[J]. Phytochemistry, 2001, 56(4): 383-386.

[17]

Coune CA, Angenot LJG, Denoël J. 13C NMR des alcaloïdes des strychnos: les dérivés de l'harmane et de l'usambarensine[J]. Phytochemistry, 1980, 19(9): 2009-2011.

[18]

Herath W, Mikell JR, Ferreira D, et al. Microbial metabolites of harman alkaloids[J]. Chem Pharm Bull, 2003, 51(6): 646-648.

[19]

Seki H, Hashimoto A, Hino T. The 1H- and 13C-nuclear magnetic resonance spectra of harman. Reinvestigation of the assignments by one- and two-dimensional methods[J]. Chem Pharm Bull, 1993, 41(6): 1169-1172.

[20]

Berrougui H, Martín-Cordero C, Khalil A, et al. Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seed’s in isolated rat aorta[J]. Pharmacol Res, 2006, 54(2): 150-157.

[21]

Salimuzzaman S, Obaid YK, Shaheen F, et al. Studies in the chemical constituents of the seeds of Pegnum harmala: isolation and structure elucidation of two β-carboline lactams-harmalanine and harmalacidine[J]. Heterocycles, 1988, 27(6): 1401-1410.

[22]

Kumar K, Wang P, Sanchez R, et al. Development of kinase-selective, harmine-based DYRK1A inhibitors that induce pancreatic human β-cell proliferation[J]. J Med Chem, 2018, 61(17): 7687-7699.

[23]

Wang F, Hua HM, Pei YH et al. Triterpenoids from the resin of Styrax tonkinensis and their antiproliferative and differentiation effects in human leukemia HL-60 cells[J]. J Nat Prod, 2006, 69(5): 807-810.

[24]

Mosmann TJ. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays[J]. J Immunol Methods, 1983, 65(1-2): 55-63.

Funding

National Natural Science Foundation of China(81773604)

National Science and Technology Major Project of the Ministry of Science and Technology of China(2018ZX09735005)

Doctoral Scientific Research Fund Project of Nanyang Institute of Technology(510197)

Interdisciplinary Sciences Project, Nanyang Institute of Technology(520097)

PDF (1031KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/